The prognostic values of EGFR expression and KRAS mutation in patients with synchronous or metachronous metastatic colorectal cancer.
about
Clinical Implications and Future Perspectives of Circulating Tumor Cells and Biomarkers in Clinical Outcomes of Colorectal CancerTranslational progress on tumor biomarkersAssociation between clinicopathological features and survival in patients with primary and paired metastatic colorectal cancer and KRAS mutation.KRAS mutation in adenocarcinoma of the gastrointestinal type arising from a mature cystic teratoma of the ovary.Localization of phosphorylated ErbB1-4 and heregulin in colorectal cancerHigh SHIP2 expression indicates poor survival in colorectal cancer.Up-front systemic chemotherapy is a feasible option compared to primary tumor resection followed by chemotherapy for colorectal cancer with unresectable synchronous metastases.High Rab27A expression indicates favorable prognosis in CRC.Expression of Vascular Endothelial Growth Factor (VEGF) and Epidermal Growth Factor Receptor (EGFR) in Patients With Serous Ovarian Carcinoma and Their Clinical Significance.LINC01225 promotes occurrence and metastasis of hepatocellular carcinoma in an epidermal growth factor receptor-dependent pathway.Blood-based markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance)Coexistence of MSI with KRAS mutation is associated with worse prognosis in colorectal cancer64Cu-Labeled Gp2 Domain for PET Imaging of Epidermal Growth Factor Receptor.Influence of mRNA expression of epiregulin and amphiregulin on outcome of patients with metastatic colorectal cancer treated with 5-FU/LV plus irinotecan or irinotecan plus oxaliplatin as first-line treatment (FIRE 1-trial).Overexpression of MutL homolog 1 and MutS homolog 2 proteins have reversed prognostic implications for stage I-II colon cancer patients.EGFR expression in patients with stage III colorectal cancer after adjuvant chemotherapy and on cancer cell function.RAS/BRAF Circulating Tumor DNA Mutations as a Predictor of Response to First-Line Chemotherapy in Metastatic Colorectal Cancer Patients.Upregulation of c-mesenchymal epithelial transition expression and RAS mutations are associated with late lung metastasis and poor prognosis in colorectal carcinoma.
P2860
Q26738587-B59938CD-C38F-43DE-8E2B-A840B0DC7826Q26777676-E417BB80-3195-442C-ABF4-08329B2591E5Q33739940-BB0AC56B-A6CB-4752-99C0-1BAF809CE3FCQ34233861-DC6BCD37-0098-486D-A8C4-56F4CE60A48CQ34586892-FCE03B53-8ED6-4027-9A02-D832B96FCE94Q34694755-F846EC64-4BC8-440F-B42B-CEC9869F795EQ35589315-D8143C60-6B30-42F7-AEB5-2F0DD86AF075Q35736686-3EA2908D-522C-423C-985D-E490380E6F2BQ36163297-D93D0B86-DF17-4005-9B99-4C3F43ABD6B0Q36774942-50C419B1-2C61-443E-BC3D-5F5F6AD7715DQ37321131-DD81B741-155B-4605-85E1-A62FD9A5927FQ37608405-E9DC4D13-BE64-49EF-ADA2-CABC958F049CQ38815325-D864C33F-A667-4810-9A48-6C35A862DE40Q41473710-8685019A-C6B3-4CA3-87B0-1B7BED4A152AQ47793305-8A6281D2-F6C4-425A-8F54-89D297BE108FQ49569642-5331FA2A-47B5-4C33-A919-A5037ACE2B86Q55358017-DC2A93A3-5507-4311-9ABA-7E076E6FDABAQ55408333-9035A7BF-774D-4DF7-B807-9042E1B6D1DB
P2860
The prognostic values of EGFR expression and KRAS mutation in patients with synchronous or metachronous metastatic colorectal cancer.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The prognostic values of EGFR ...... metastatic colorectal cancer.
@ast
The prognostic values of EGFR ...... metastatic colorectal cancer.
@en
type
label
The prognostic values of EGFR ...... metastatic colorectal cancer.
@ast
The prognostic values of EGFR ...... metastatic colorectal cancer.
@en
prefLabel
The prognostic values of EGFR ...... metastatic colorectal cancer.
@ast
The prognostic values of EGFR ...... metastatic colorectal cancer.
@en
P2093
P2860
P356
P1433
P1476
The prognostic values of EGFR ...... s metastatic colorectal cancer
@en
P2093
Chao-Hung Kuo
Chee-Yin Chai
Cheng-Jen Ma
Chien-Yu Lu
Ching-Wen Huang
Chun-Ming Huang
Deng-Chyang Wu
Hsiang-Lin Tsai
Jaw-Yuan Wang
P2860
P2888
P356
10.1186/1471-2407-13-599
P407
P50
P577
2013-12-13T00:00:00Z
P5875
P6179
1045617821